Nobuaki Shindoh

693 total citations
17 papers, 418 citations indexed

About

Nobuaki Shindoh is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Nobuaki Shindoh has authored 17 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Nobuaki Shindoh's work include Histone Deacetylase Inhibitors Research (6 papers), Fibroblast Growth Factor Research (4 papers) and Synthesis and Catalytic Reactions (4 papers). Nobuaki Shindoh is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Fibroblast Growth Factor Research (4 papers) and Synthesis and Catalytic Reactions (4 papers). Nobuaki Shindoh collaborates with scholars based in Japan, Netherlands and United Kingdom. Nobuaki Shindoh's co-authors include Yoshiko Shimizu, Satoshi Minoshima, Jun Kudoh, Yoh Terada, Koji Nagai, Nobuyoshi Shimizu, Rob W. M. van Soest, Nobuhiro Fusetani, Jun K. Yamashita and Yoichi Nakao and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Cancer Research.

In The Last Decade

Nobuaki Shindoh

17 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuaki Shindoh Japan 10 302 80 79 76 69 17 418
Victor P. Ghidu United States 6 373 1.2× 99 1.2× 54 0.7× 28 0.4× 9 0.1× 7 466
H Ogino Japan 5 234 0.8× 186 2.3× 15 0.2× 32 0.4× 79 1.1× 7 370
Aya Kurosawa Japan 14 418 1.4× 135 1.7× 32 0.4× 42 0.6× 23 0.3× 28 476
Hermann Oberhuber Austria 11 279 0.9× 89 1.1× 24 0.3× 24 0.3× 20 0.3× 16 376
Ayumi Tsukamoto Japan 9 228 0.8× 110 1.4× 16 0.2× 85 1.1× 10 0.1× 23 380
Elena Delgado Spain 6 182 0.6× 105 1.3× 23 0.3× 22 0.3× 31 0.4× 7 438
Meryem Alagöz Türkiye 10 336 1.1× 119 1.5× 16 0.2× 62 0.8× 21 0.3× 17 430
S. A. Shellard United Kingdom 7 230 0.8× 139 1.7× 26 0.3× 35 0.5× 20 0.3× 8 359
Byron J. Aguilar United States 12 232 0.8× 66 0.8× 22 0.3× 27 0.4× 7 0.1× 20 390
Rahul Sanawar India 7 210 0.7× 74 0.9× 14 0.2× 34 0.4× 6 0.1× 14 310

Countries citing papers authored by Nobuaki Shindoh

Since Specialization
Citations

This map shows the geographic impact of Nobuaki Shindoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuaki Shindoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuaki Shindoh more than expected).

Fields of papers citing papers by Nobuaki Shindoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuaki Shindoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuaki Shindoh. The network helps show where Nobuaki Shindoh may publish in the future.

Co-authorship network of co-authors of Nobuaki Shindoh

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuaki Shindoh. A scholar is included among the top collaborators of Nobuaki Shindoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuaki Shindoh. Nobuaki Shindoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Futami, T., Tatsuya Kawase, Kenichi Mori, et al.. (2019). Identification of a novel oncogenic mutation of FGFR4 in gastric cancer. Scientific Reports. 9(1). 14627–14627. 15 indexed citations
2.
Futami, T., Hidetsugu Okada, Rumi Kihara, et al.. (2016). ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 16(1). 68–75. 34 indexed citations
3.
Suzuki, Tomoyuki, Ayako Nakayama, Tohru Ozawa, et al.. (2016). ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance. Cancer Science. 108(2). 236–242. 22 indexed citations
4.
Futami, T., Hidetsugu Okada, Rumi Kihara, et al.. (2015). Abstract A172: Preclinical antitumor activity of ASP5878, a novel inhibitor of FGFR1, 2, 3 and 4, in FGF19-expressing hepatocellular carcinoma. Molecular Cancer Therapeutics. 14(12_Supplement_2). A172–A172. 1 indexed citations
5.
Yoda, Akinori, Guillaume Adelmant, Nobuaki Shindoh, et al.. (2013). Abstract PR07: Novel oncogenic mutations in the beta subunit of heteromeric G-proteins identified by functional cDNA library screening.. Molecular Cancer Therapeutics. 12(11_Supplement). PR07–PR07. 1 indexed citations
6.
Shindoh, Nobuaki, Akinori Yoda, Yuka Yoda, et al.. (2012). Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes. PLoS ONE. 7(11). e49201–e49201. 4 indexed citations
7.
Kuromitsu, Sadao, Masamichi Mori, Itsuro Shimada, et al.. (2011). Abstract 2821: Anti-tumor activity of ASP3026, – A novel and selective ALK inhibitor -. Cancer Research. 71(8_Supplement). 2821–2821. 9 indexed citations
8.
Kuromitsu, Sadao, Masamichi Mori, Nobuaki Shindoh, et al.. (2011). Abstract A227: Antitumor activities of ASP3026 against EML4-ALK-dependent tumor models.. Molecular Cancer Therapeutics. 10(11_Supplement). A227–A227. 15 indexed citations
9.
Shindoh, Nobuaki, et al.. (2008). Histone deacetylase inhibitors from microorganisms: the Astellas experience. Birkhäuser Basel eBooks. 66. 335–359. 16 indexed citations
10.
Shindoh, Nobuaki, Masamichi Mori, Yoh Terada, et al.. (2008). YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model. International Journal of Oncology. 32(3). 545–55. 31 indexed citations
11.
Nakao, Yoichi, Satoru Yoshida, Shigeki Matsunaga, et al.. (2007). Azumamides A‐E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge Mycale izuensis.. ChemInform. 38(11). 3 indexed citations
12.
Nakao, Yoichi, Satoru Yoshida, Shigeki Matsunaga, et al.. (2006). Azumamides A–E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge Mycale izuensis. Angewandte Chemie International Edition. 45(45). 7553–7557. 80 indexed citations
13.
Nakao, Yoichi, Satoru Yoshida, Shigeki Matsunaga, et al.. (2006). Azumamides A–E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge Mycale izuensis. Angewandte Chemie. 118(45). 7715–7719. 7 indexed citations
14.
Nakao, Yoichi, Satoru Yoshida, Shigeki Matsunaga, et al.. (2006). Titelbild: Azumamides A–E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge Mycale izuensis / Total Synthesis of Azumamides A and E (Angew. Chem. 45/2006). Angewandte Chemie. 118(45). 7637–7637. 1 indexed citations
15.
Oku, Naoya, Koji Nagai, Nobuaki Shindoh, et al.. (2004). Three new cyclostellettamines, which inhibit histone deacetylase, from a marine sponge of the genus Xestospongia. Bioorganic & Medicinal Chemistry Letters. 14(10). 2617–2620. 36 indexed citations
16.
Shindoh, Nobuaki, et al.. (1996). Cloning of a Human Homolog of theDrosophila Minibrain/Rat Dyrk Gene from “the Down Syndrome Critical Region” of Chromosome 21. Biochemical and Biophysical Research Communications. 225(1). 92–99. 102 indexed citations
17.
Noda, Setsuko, Jun Kudoh, Nobuaki Shindoh, et al.. (1996). The MammalianSingle-Minded(SIM) Gene: Mouse cDNA Structure and Diencephalic Expression Indicate a Candidate Gene for Down Syndrome. Genomics. 35(1). 136–143. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor P. Ghidu Breakdown of academic impact, for papers by H Ogino Breakdown of academic impact, for papers by Aya Kurosawa Breakdown of academic impact, for papers by Hermann Oberhuber Breakdown of academic impact, for papers by Ayumi Tsukamoto Breakdown of academic impact, for papers by Elena Delgado Breakdown of academic impact, for papers by Meryem Alagöz Breakdown of academic impact, for papers by S. A. Shellard Breakdown of academic impact, for papers by Byron J. Aguilar Breakdown of academic impact, for papers by Rahul Sanawar
Rankless by CCL
2026